Market Place
Sourcing Support
NRx Pharma Announces Advance of $5 Million Milestone Payment from Alvogen
11 Feb 2024 //
PR NEWSWIRE
Alvogen snags NRx`s bipolar depression drug in $330M deal
07 Jun 2023 //
FIERCE BIOTECH
Enforcement Report - Week of March 8, 2023
08 Mar 2023 //
FDA
AZ hit with fine in Korea over plot to stall generic of lucrative cancer med
14 Oct 2022 //
FIERCEPHARMA
Bausch Health Responds to Norwich Tentative FDA Approval for a 200 mg Rifaximin
09 Sep 2022 //
PRNEWSWIRE
Norwich`s Generic Rifaximin Receives Approval in the U.S.
02 Sep 2022 //
FDA
Alvogen Announces Ruling on Patents Related to the Company’s Proposed Generic
11 Aug 2022 //
BUSINESSWIRE
Alvogen Generic Nitrofurantoin Receives Approval in the U.S.
20 Jul 2022 //
FDA
Aztiq and Innobic conclude acquisition of AEMH for $500m
10 May 2022 //
PHARMACEUTICAL-TECHNOLOGY
Poland’s largest pharma eyes Zentiva buyout: report
22 Jan 2022 //
FIERCEPHARMA
Biotech billionaire Róbert Wessman engineers $450M deal for Alvogen subsidiaries
29 Nov 2021 //
ENDPTS
A Powerful Investment Alliance of Aztiq and Innobic Acquires Alvogen’s Shares
26 Nov 2021 //
BUSINESSWIRE
Aztiq-Innobic consortium to buy Alvogen subsidiary for $475m
26 Nov 2021 //
PHARMACEUTICAL-TECHNOLOGY
AbbVie Says Court Rules Imbruvica Patents Valid in Generic Challenge
21 Aug 2021 //
MORNING STAR
Alvogen`s Generic Buprenorphine HCl Receives Approval In US
03 Aug 2021 //
FDA
Enforcement Report - Week of July 14, 2021
14 Jul 2021 //
FDA
Alvogen`s Generic Pregabalin Receives Approval In US
06 Jul 2021 //
FDA
Aztiq Buys 17% Stake in Alvogen US
30 Jun 2021 //
BUSINESSWIRE
Alvogen Inc`s Generic Ibrutinib Receives Tentative Approval In US
03 Jun 2021 //
FDA
Alvogen`s Generic Tolcapone Receives Approval in the US
29 Jul 2020 //
FDA
Luye Pharma raises awareness on mental health
01 Jun 2020 //
BIOSPECTRUMASIA
Alvogen Malta`s Generic Hydrocodone bitartrate Receives Approval in the U.S
22 Jan 2020 //
FDA
Alvogen Pharma`s Generic Hydrocodone bitartrate Receives Approval in U.S
21 Jan 2020 //
FDA
FDA Action Alert: PFEnex, Flexion, Alexion and Clearside
08 Oct 2019 //
BIOSPACE
Enforcement Report - Week of August 21, 2019
21 Aug 2019 //
FDA
Enforcement Report - Week of May 15, 2019
15 May 2019 //
FDA
Natco Pharma`s marketing partner gets USFDA approval for chest pain tablets
07 May 2019 //
MONEY CONTROL
Pfenex & Alvogen Expand Development, Commercialization Collaboration for PF708
28 Feb 2019 //
GLOBENEWSWIRE.COM/NEWS-RELEASE/2019/02/2
Alvogen Launches Generic Equivalent to Suboxone® (Buprenorphine/Naloxone)
20 Feb 2019 //
PR NEWSWIRE
Just as it`s enjoying a reprieve in the US Celgene`s Revlimid generic rival EU
14 Feb 2019 //
FIERCE PHARMA
Janumet XR (metformin HCl; sitagliptin phosphate) : Merck vs. Alvogen PB
13 Feb 2019 //
PATENT LITIGATION
Alvogen`s Generic Buprenorphine HCl; Naloxone HCl Receives Approval in US
24 Jan 2019 //
FDA
Death row inmate whose execution was postponed found dead in cell
11 Jan 2019 //
PHARMA FILE
Alvogen PB`s Generic Methylphenidate Hydrochloride Receives Approval in US
30 Nov 2018 //
FDA
Belbuca (Buprenorphine) : BioDelivery Sciences v. Alvogen Pb R&D
11 Sep 2018 //
PATENT LITIGATION
Drugmaker blocks Nevada execution
30 Jul 2018 //
CHEMISTRY WORLD
Lawmaker urges Pfizer to sue over lethal injection procedure
30 Jul 2018 //
FIERCE PHARMA
Alvogen`s Generic Ethacrynic Acid Receives Approval in US
26 Jul 2018 //
FDA
Revlimid® (Lenalidomide): Celgene Corporation v. Lotus Pharmaceutical Co., Alvogen Group, Inc.
16 Jul 2018 //
PATENT LITIGATION
US prison ‘fraudulently’ obtained sedative for lethal injection, claims Alvogen
12 Jul 2018 //
IN-PHARMATECHNOLOGIST
CVC revs up rare disease ambitions with $3.5B Recordati buy
05 Jul 2018 //
FIERCE PHARMA
Prestige Biopharma, Alvogen unite to market Hervelous in Europe
29 Jun 2018 //
BIOSPECTRUM
Prestige BioPharma, Alvogen Enter Agreement
28 Jun 2018 //
CONTACT PHARMA
Pomalyst® (Pomalidomide Capsules) : Celgene Corporation v. Synthon
21 Jun 2018 //
PATENT LITIGATION
Generics group Alvogen puts Eastern European ops up for sale: sources
20 Apr 2018 //
REUTERS
Suboxone®(buprenorphine HCL & Naloxone HCL) : Indivior v. Alvogen Pine Brook
03 Apr 2018 //
PATENT LITIGATION
Indivior loses patent battle with generics maker Alvogen
24 Mar 2018 //
ENDPTS
Alvogen`s Generic Esomeprazole Magnesium Receives Approval In US
08 Mar 2018 //
FDA
Natco`s partner Alvogen gets nod for influenza drug in US
03 Nov 2017 //
ECONOMIC TIMES
Alvogen’s Generic Oseltamivir Phosphate Receives Approval In US
03 Nov 2017 //
FDA
Teva`s Copaxone faces generic competition in Europe after U.S. hit
05 Oct 2017 //
REUTERS
CVC to Explore Options for $4 Billion Drugmaker Alvogen
26 Sep 2017 //
BLOOMBERG
Indivior reaches settlement with Mylan over patent dispute
26 Sep 2017 //
PHARMAFILE
As drug prices drop, generics makers fight back with deals
28 Jul 2017 //
REUTERS
